Person-centered choice and mHealth support for same-day delivery of long-acting injectable cabotegravir (ImPrEP CAB Brasil): a prospective, open-label, multicenter, quasi-experimental implementation study
Thiago Silva Torres, Brenda Hoagland, Carolina Coutinho, Mayara Secco Torres Silva, Ronaldo Ismério Moreira, Iuri Costa Leite, Marcelo Cunha, Emilia M. Jalil, Sandra Wagner Cardoso, Roberta Trefiglio, Alessandro Farias, Maria Paula G. Mourão, José Valdez Madruga, Josué N. de Lima, Ronaldo Zonta, Gabrielle O'Malley, Julio Moreira, Keila Simpson, Heather A. Pines, Alex R. Rinehart, Nanlesta Pilgrim, Paula M. Luz, Marcos Benedetti, Maria Cristina Pimenta, Valdilea Gonçalves Veloso, Beatriz Grinsztejn, ImPrEP CAB Brasil Study Group · 2026
Read Person-centered choice and mHealth support for same-day delivery of long-acting injectable cabotegravir (ImPrEP CAB Brasil): a prospective, open-label, multicenter, quasi-experimental implementation study by Thiago Silva Torres, Brenda Hoagland, Carolina Coutinho, Mayara Secco Torres Silva, Ronaldo Ismério Moreira, Iuri Costa Leite, Marcelo Cunha, Emilia M. Jalil, Sandra Wagner Cardoso, Roberta Trefiglio, Alessandro Farias, Maria Paula G. Mourão, José Valdez Madruga, Josué N. de Lima, Ronaldo Zonta, Gabrielle O'Malley, Julio Moreira, Keila Simpson, Heather A. Pines, Alex R. Rinehart, Nanlesta Pilgrim, Paula M. Luz, Marcos Benedetti, Maria Cristina Pimenta, Valdilea Gonçalves Veloso, Beatriz Grinsztejn, ImPrEP CAB Brasil Study Group (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13279416.txt.
Description
Thiago Silva Torres and a large team report a 2026 study of HIV prevention choice in Brazil. The study, ImPrEP CAB Brasil, offered a long acting shot called cabotegravir as a stand in for daily prevention pills. Young men and gender diverse people who have sex with men, aged eighteen to thirty, joined at six public health sites. A phone health tool helped users weigh their options.
The design was open label and quasi experimental, run in real clinics, not a blind trial. The phone tool won high marks: more than ninety percent called it easy, clear, useful and pleasing. Tool use raised the share who chose the shot. Top reasons were trouble with daily pills for the shot, and dislike of needles for pills. The work gives Brazil health leaders real world proof for person led prevention.
Catalog record
| CREATOR | Thiago Silva Torres, Brenda Hoagland, Carolina Coutinho, Mayara Secco Torres Silva, Ronaldo Ismério Moreira, Iuri Costa Leite, Marcelo Cunha, Emilia M. Jalil, Sandra Wagner Cardoso, Roberta Trefiglio, Alessandro Farias, Maria Paula G. Mourão, José Valdez Madruga, Josué N. de Lima, Ronaldo Zonta, Gabrielle O'Malley, Julio Moreira, Keila Simpson, Heather A. Pines, Alex R. Rinehart, Nanlesta Pilgrim, Paula M. Luz, Marcos Benedetti, Maria Cristina Pimenta, Valdilea Gonçalves Veloso, Beatriz Grinsztejn, ImPrEP CAB Brasil Study Group |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59079 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |